GHB-001 / Gatehouse Bio - LARVOL DELTA

Gatehouse Bio Announces Upcoming Presentation at RNA Leaders Europe Congress (Businesswire) - "Gatehouse Bio...announced today that its Chief Executive Officer, David W. Salzman, PhD, will present at the upcoming RNA Leaders Europe Congress, in Basel, Switzerland on March 15, 2023 at 12:20PM CET. In the presentation, Dr. Salzman will describe Gatehouse Bio’s AI-powered Code-Breaker™ Platform and discuss one of the company’s preclinical drug candidates, GHB1589M, an inhaled oligonucleotide therapeutic for idiopathic pulmonary fibrosis, or IPF."

Preclinical • Idiopathic Pulmonary Fibrosis